Director/PDMR Shareholding

RNS Number : 6672H
NatWest Group plc
25 November 2022
 

25 November 2022

 

NatWest Group plc

 

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ("PDMRs") IN ACCORDANCE WITH ARTICLE 19 OF THE MARKET ABUSE REGULATION

 

1.  NatWest Group plc (the "Company") announces that options to acquire ordinary shares of £1.0769* each in the Company ("Shares") (ISIN:GB00BM8PJY71) were granted to PDMRs on 25 November 2022 under the NatWest Group plc 2017 UK ShareSave Plan ("Plan"), at the option price of £1.8619 per Share, as set out below.

 

 

Name of PDMR

 

 

Position of PDMR

 

No. of options granted

 

 

Scott Marcar

 

 

Chief Information Officer

1,933

 

Andrew McLaughlin

 

 

CEO, Commercial & Institutional for the non-ring-fenced bank

 

1,933

 

Subject to the rules of the Plan, the options will become exercisable from 18 December 2025. This transaction took place outside of a trading venue.

 

2.  The Company also announces that it has been notified of the PDMRs set out below selling Shares on the date and at the price indicated:

 

Name of PDMR

Position of PDMR

No. of Shares sold

Price of Shares sold

 

Date  Shares sold

 

Robert Begbie

 

CEO, NatWest Markets

 

200,000

 

£2.5445

 

23 November 2022

 

 

Andrew McLaughlin

 

 

 

CEO, Commercial & Institutional for the non-ring-fenced bank

 

 

164,495

 

£2.5878

 

24 November 2022

 

The above transactions took place on the London Stock Exchange (XLON).

 

* Note: the nominal value of ordinary shares without rounding is £1.076923076923077 per share  

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

 

For further information contact:-

 

NatWest Group Investor Relations
Alexander Holcroft
Head of Investor Relations
+44(0)20 7672 1758

 

NatWest Group Media Relations  

+44(0)131 523 4205

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFEEFEIEESEIF
UK 100

Latest directors dealings